+++
title = "HeartBeam Inc. to Unveil Q1 2025 Financial Results and Business Update, Highlighting Innovations in Cardiac Care"
date = "2025-05-01T13:55:22Z"
draft = false
summary = "<p>HeartBeam (NASDAQ: BEAT) will host a conference call on May 13 at 4:30 p.m. Eastern to discuss financial results for the first quarter ended March 31, 2025. CEO Robert Eno and CFO Timothy Cruickshank will lead the call, which will include updates on regulatory progress, commercial-readiness efforts, and upcoming milestones. A corresponding press release and presentation will be available on the company’s investor relations website.</p> <p>HeartBeam is a medical technology company dedicated to transforming cardiac care by providing powerful cardiac insights wherever the patient is. The company is creating the first-ever cable-free 12-lead ECG capable of capturing the heart’s electrical signals from three dimensions. Physicians will be able to identify cardiac health trends and acute conditions and direct patients to appropriate care outside of a medical facility. For more information, visit <a href=\"http://www.heartbeam.com/\" rel=\"noreferrer noopener\">www.HeartBeam.com</a>.</p>"
description = "HeartBeam (NASDAQ: BEAT) to discuss first quarter financial results in conference call on May 13. Learn about the company's innovative cable-free 12-lead ECG technology and its potential to transform cardiac care. Visit www.HeartBeam.com for more information."
source_link = "https://rss.investorbrandnetwork.com/iw/investornewsbreaks-heartbeam-inc-nasdaq-beat-to-report-q1-2025-results-and-provide-business-update-on-may-13/"
enclosure = "https://cdn.newsramp.app/banners/health-wellness-2.jpg"
article_id = 85389
feed_item_id = 13695
url = "2025-05-01-heartbeam-inc-to-unveil-q1-2025-financial-results-and-business-update-highlighting-innovations-in-cardiac-care"
qrcode = "https://cdn.newsramp.app/ibn/qrcode/255/1/fast6rT3.webp"
source = "InvestorBrandNetwork (IBN)"
+++

<p>HeartBeam Inc. (NASDAQ: BEAT), a leader in medical technology innovation, is gearing up to share its first quarter 2025 financial results and a detailed business update in a conference call scheduled for May 13 at 4:30 p.m. Eastern time. The event, led by CEO Robert Eno and CFO Timothy Cruickshank, is anticipated to shed light on the company's strategic direction and recent achievements, particularly in the realm of cardiac care solutions.</p><p>At the heart of HeartBeam's innovation is its development of a cable-free 12-lead ECG technology, a groundbreaking platform designed to capture three-dimensional heart electrical signals. This technology stands to redefine cardiac health management by enabling physicians to monitor heart health remotely, offering a new dimension of actionable intelligence outside conventional medical settings. Such advancements could significantly enhance early detection and intervention for cardiac conditions, marking a pivotal shift in patient care.</p><p>With a robust portfolio of 13 U.S. and 4 international patents, HeartBeam is carving out a niche as a potential game-changer in the cardiac monitoring space. The upcoming conference call is expected to delve into the company's progress regarding regulatory approvals, commercial readiness, and key milestones, providing stakeholders with a clear view of its trajectory.</p><p>For investors and healthcare professionals alike, the May 13 conference call represents a critical opportunity to gain insights into HeartBeam's financial health, technological breakthroughs, and strategic initiatives. The discussion is poised to highlight how the company's innovations could impact the broader healthcare industry, offering a glimpse into the future of cardiac care.</p>